Alnylam Pharmaceuticals
ALNY
#449
Rank
$51.80 B
Marketcap
$392.10
Share price
0.24%
Change (1 day)
59.02%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company